82 results
Page 3 of 5
8-K
EX-99.2
70d3gz
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
EX-10.56
e9h0xo yqb
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.21
5hi5mcmlz e3ysf0
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
q98vbft iua
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
l0i1ww
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
DEF 14A
zmyqia42ie
6 Apr 20
Definitive proxy
4:52pm
10-K
EX-10.20
k6plonb53it1vv6
26 Mar 20
Annual report
4:08pm
10-K
EX-10.19
tb7rdog8yaw l6
26 Mar 20
Annual report
4:08pm
10-K
EX-10.22
izwub8evk3e8p nlylo
26 Mar 20
Annual report
4:08pm
10-K
oori8754m4dragiuw dp
26 Mar 20
Annual report
4:08pm
10-Q
0123q24010x20oehc0i
19 Nov 19
Quarterly report
4:06pm
S-8
EX-4.8
nhsvslks0dk2k7 m9n
15 Oct 19
Registration of securities for employees
4:47pm
424B4
7tygoc4l
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
EX-10.2
hou6t5
30 Sep 19
IPO registration (amended)
6:12am
S-1/A
EX-3.1
ysmu5yn 2abde4
30 Sep 19
IPO registration (amended)
6:12am
S-1/A
snmt58n c9
30 Sep 19
IPO registration (amended)
6:12am
S-1
EX-10.24
9jtij
3 Sep 19
IPO registration
4:40pm
S-1
EX-3.1
87b3ify4qcv7huz61
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.22
bukwmh
3 Sep 19
IPO registration
4:40pm